Jaclyn is a Health Economist and Manager of the Pharmacoeconomics Research Unit at Ontario Health (Cancer Care Ontario), where she helps bridge research and policy to assess and interpret cost-effectiveness of new cancer therapies. Her interests include economic evaluations, real-world evidence, and enhancing the role of pharmacoeconomic evidence in reimbursement decisions. She is pursuing her PhD in Health Services Research with focus on Health Technology Assessment at the University of Toronto.
Agenda: Day 1 Oct 5, 2020
Agenda: Day 2 Oct 6, 2020
Panel Discussion: HEALTH ECONOMICS
PERSPECTIVE IS EVERYTHING – WHAT AND WHO SHOULD COUNT?
This session will explore the concept of a societal perspective vs a MOH perspective in economic evaluations. Should certain disease areas be assessed based on a societal perspective? The panel will explore this for rare diseases, Chronic diseases and Cancer.